“Prospective, Case-Control Study of Serological Response After Two Doses of BNT162b2 Anti-SARS-CoV-2 MRNA Vaccine in Transfusion-Dependent Thalassemic Patients”. 2022. Mediterranean Journal of Hematology and Infectious Diseases 14 (1): e2022056. https://doi.org/10.4084/MJHID.2022.056.